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Background: Viscoelastic tests enable a time-efficient analysis of coagulation properties. An 
important limitation of viscoelastic tests is the complicated presentation of their results in the form of 
abstract graphs with a multitude of numbers. We developed Visual Clot to simplify the interpretation of 
presented clotting information. This visualization technology applies user-centered design principles to 
create an animated model of the blood clot during the current hemostatic cascade. In a previous 
simulation study, we found Visual Clot to double diagnostic accuracy, reduce time to decision making, 
and perceived workload, and improve care providers’ confidence. 
Objective: This study aimed to investigate the opinions of physicians on Visual Clot technology. It 
further aimed to assess its strengths, limitations and its clinical applicability as a support tool for 
coagulation management. 
Methods: This is a researcher-initiated, international, double-center mixed qualitative quantitative 
study including the anesthesiologists and intensive care physicians who participated in the previous 
Visual Clot study. After the participants solved six coagulation scenarios using Visual Clot, we 
questioned them about the perceived pros and cons of this new tool. Employing qualitative research 
methods, we identified recurring answer patterns, and derived major topics and subthemes through 
inductive coding. Based on them, we defined six statements. The study participants rated their agreement 
to these statements later on five-point Likert scales in an online survey, providing the quantitative part 
of this study. 
Results: A total of sixty physicians participated in the primary Visual Clot study. Thirty-six of them 
gave an interview, and forty-two completed the online survey. In total, eight different major topics were 
derived from the interview field note responses. The three most common topics were “positive design 
features” (29 of 36, 81%), “facilitates decision making” (17 of 36, 47%), and “quantification not made” 
(17 of 36, 47%). In the online survey, ninety-three percent (39 of 42) agreed to the statement that Visual 
Clot is intuitive and easy to learn. Ninety percent (38 of 42) of the participants agreed that they would 
like the standard result, and Visual Clot displayed on the screen side by side. Eighty-six percent (36 of 
42) indicated that Visual Clot allows them to deal with complex coagulation situations more quickly. 
Conclusions: A group of anesthesia and intensive care physicians from two University hospitals in 
central Europe considered Visual Clot technology to be intuitive, easy to learn, and useful for decision 
making in situations of active bleeding. From the responses of these possible future users, Visual Clot 
appeared to constitute an efficient and well-accepted way to streamline the decision making process in 
viscoelastic test based coagulation management. 
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For optimal perioperative bleeding management, a quick and reliable assessment of the patient’s blood 
coagulation function is of utmost importance [1-3]. As laboratory coagulation testing can take more than 
an hour [4] to produce results, viscoelastic point-of-care devices such as rotational thromboelastometry 
(ROTEM, Instrumentation Laboratory/Werfen Bedford, MA, USA) and thromboelastography (TEG, 
Haemonetics, Boston, MA, USA) play an important role in guiding hemostatic interventions in a time-
efficient manner [5]. Previous studies showed that the utilization of viscoelastic testing can improve 
patient outcome in bleeding trauma patients [3, 6-9]. Hence, the European guidelines on trauma 
management recommend viscoelastic testing to enable goal-directed bleeding management [10]. 
Furthermore, viscoelastic point-of-care coagulation testing reduces the transfusion of allogeneic blood 
products in trauma [2, 10]. Previous studies also showed benefits of its use in cardiac [1, 11, 12], 
transplant [13], neuro [14], and pediatric surgery [5]. 
However, the abstract presentation of the viscoelastic test results complicates its handling in clinical 
routine. This in turn shows the demand for a tool that facilitates the interpretation of viscoelastic 
readings. To serve this apparent need, Visual Clot technology [15] was developed. Visual Clot is an 
alternative situation awareness-oriented visualization technology created adhering to the principles of 
user-centered design [16]. Instead of abstract shapes and a multitude of numbers, as in the conventional 
presentation of the ROTEM results, Visual Clot technology displays a three-dimensional, animated 
model of the blood clot that corresponds to the real phenomena one would see when looking at the blood 
clot through an electron microscope. In an international, dual center study [15], Visual Clot technology 
enabled the participating physicians to make twice as many correct diagnoses, quicker, with improved 
diagnostic confidence, and with reduced perceived cognitive workload compared to standard 
viscoelastic test results. 
This study aimed to explore and capture the opinions of the 60 anesthesiologists and intensive care 
specialists of the previous Visual Clot study [15] on this new visualization technology. Its results will 
help define the strengths and limitations of this visual decision aid. Further, this study examines the 
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applicability of Visual Clot as an additional tool for coagulation management from the viewpoint of its 
potential future users.   
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Methods 
The leading ethics committee, the Cantonal Ethics Committee of the Canton of Zurich in Switzerland, 
reviewed the study protocol and issued a declaration of no objection (Business Management System for 
Ethics Committees Number 2018-00933). We obtained written informed consent from each participant 
for the use of their data.  
Study design 
We conducted this study at the University Hospital Frankfurt (UKF) in Germany and the University 
Hospital Zurich (USZ) in Switzerland. We included anesthesiologists and intensive care physicians from 
these two hospitals. Both study centers routinely use ROTEM-guided hemostatic resuscitation.  
This study is a researcher-initiated, international, dual center, mixed qualitative quantitative study about 
the opinions of anesthesia and intensive care physicians regarding Visual Clot technology. The methods 
employed included interviewing physicians after their first contact with Visual Clot technology and 
jointly generating field notes based on their answers. Further, we created statements derived from these 
field note responses and asked the same group of physicians to rate the statements in an online survey.  
Previous Visual Clot study and participant interviews  
We held interviews for the qualitative part of this study at the end of the data collection sessions of the 
previously published Visual Clot study. In mentioned study, the participating physicians evaluated 12 
coagulation scenarios in randomized order. They solved each scenario twice, once only observing Visual 
Clot and once only using the conventional viscoelastic test results. Before the testing took place, the 
participants received a brief individual training and subsequently solved six scenarios using Visual Clot 
to become familiar with its features. We based the individual training on a Microsoft PowerPoint 
presentation (Microsoft Corporation, Redmond, WA, USA). This aimed to explain all visualizations of 
Visual Clot and enabled the participants to ask questions in case of uncertainties. Multimedia Appendix 
1 shows the training video for the current version of Visual Clot. Figure 1 explains and illustrates some 
visualizations of Visual Clot technology. 
In an undisturbed environment, we asked the physicians about the advantages and disadvantages of 
Visual Clot. There was no further guidance by the investigators, who all had previous experience with 
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qualitative research. While the physicians were encouraged to freely verbalize their thoughts, the data 
collector simultaneously took field notes in a Microsoft Word (Microsoft Corporation, Redmond, WA, 
USA) document. After the interview session, the field notes were presented to the participants. They 
were asked whether they agreed with them and were encouraged to determine final adjustments and 
changes.  
Figure 1. This graphic illustrates Visual Clot technology. A: The different coagulation components that 
Visual Clot represents as either present or absent (when dashed). B: A healthy Visual Clot with all 
coagulation elements present in sufficient quantity. C: A bleeding Visual Clot with heparin effect. D: A 
bleeding Visual Clot indicating the absence of plasmatic factors.  
 
Qualitative analysis 
We used a template approach in the qualitative analysis [17]. This involves grouping topics using a 
coding template. The topics are often predefined in advance. During further data analysis, new topics 
are added or existing ones are revised [17]. First we translated the original answers from German to 
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English using Deepl.com (DeepL GmbH, Cologne, Germany). All translated field notes are available as 
Multimedia Appendix 2. After translation, we used Microsoft Word to identify the most common words 
and created a tag cloud (Figure 2) as its quantitative graphic illustration using Wordle.net. We ignored 
common English words such as “the, and, to”, and unified word groups with the same word root. The 
two physicians and study authors TRR and DWT were both involved in the qualitative analysis of the 
field notes. TRR is a resident anesthesiologist who did not partake in the interviewing process. Study 
author DWT is a senior anesthesiologist with previous experience in qualitative and patient safety 
research. Adhering to the criteria for reporting qualitative research [18], TRR and DWT developed a 
coding template as a rating system, using both the word count and inductive coding based on recurring 
topics in the field note responses. We modified the initial coding template by successive reading, coding 
of the data and discussions with other authors. After multiple data coding, we agreed upon a final 
template. The two study authors mentioned above then independently rated all field notes using 
illustrated final coding template, which we provide in Figure 3. Inter-rater reliability was calculated to 
investigate the consistency of the implementation of the rating system. In cases of disagreement between 
these two examiners, a final code for the respective field note response was jointly determined.  
Quantitative analysis 
Literature provides several arguments why qualitative data could be combined with a quantitative 
analysis. One of the reasons for this is that quantitative data can help to generalize and confirm specific 
observations made in a qualitative analysis [19]. To further examine the qualitative research part of this 
study and Visual Clot applicability, we performed a quantitative assessment of the derived statements 
using a Web-based online survey. We defined six, partially generalized statements and asked the 
participants to rate them on five point Likert scales ranging from “strongly disagree” to “strongly agree”. 
Out of all six statements, four directly refer to the previously identified major topics. We specifically 
added two additional statements to the questioning which we considered necessary. These two aimed to 
get at a deeper understanding of Visual Clot technology applicability. Using SurveyMonkey (SVMK 
Inc., San Matteo, CA, USA), we created the open online survey and tested its usability before sending 
the study link via e-mail to all physicians who participated in the previous Visual Clot study and still 
worked at the respective institutions. We informed the participants that the survey takes about one 
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minute to fill out. Participation was voluntary, no incentives were offered and no personal identifying 
information was collected. The participants were able to review and change their answers before 
completion. A single reminder to complete the survey was sent after two weeks. Multimedia Appendix 
3 displays the translated wording of the survey invitation announcement as well as the reminder mail. 
We completed the data collection one week after the reminder period expired. 
Statistical analysis 
We provide the quantitative analysis of the online survey as median and interquartile ranges of all 
statements. Using the Wilcoxon signed-rank test, we evaluated the difference between the median for 
each of the statements and the neutral answer. We considered P <.05 to indicate statistical significance. 
The qualitative part of this study aimed to identify the pros and cons using the new visualization 
technology. With the evaluated statements of the online survey, we aimed to further quantify the agree- 
or disagreement. This procedure additionally increases the relevance of the statements made.  
Data Sharing Statement 




Study and participant characteristics  
This study includes the same participants as the previous Visual Clot study [15]. A total of 60 anesthesia 
and intensive care physicians participated, half of them working at USZ and the other half at UKF. After 
collecting data from the first 24 participants of the Visual Clot study, we decided to conduct systematic 
interviews as we found that the participants gave very informative feedback on the technology. We 
interviewed all of the participants at the UKF and six participants at the USZ, making it a total of 36 out 
of 60 (60%). Regarding the Web-based online survey, we sent out the study link as an invitation to all 
physicians who still worked at the respective institutions. We checked the IP address displayed on the 
SurveyMonkey website to identify potential duplicate entries from the same user. Since the computers 
in the hospitals are shared and the workspace usually only changes daily, we considered a difference of 
at least 24 hours appropriate for entries from the same IP address. Of all invitations sent out for the 
online survey, the participation rate was 42 out of 49 (86%). Table 1 further outlines the study and 
participant characteristics in detail.  
Table 1. Study and participant characteristics. M = mean; IQR = interquartile range; ROTEM = 
Rotational thromboelastometry. N1 = 60, N2 = 49, and N3 = 42 respectively.  
Study characteristics Values 
Total number of participants, N1 60 
Total number of interviewed participants (field notes), n of N1 (%) 36 of 60 (60) 
Online survey participation rate, n of N2 (%) 42 of 49 (86) 
Online survey completion rate, n of N3 (%) 42 of 42 (100) 
Participant characteristics Values 
Female sex, n of N1 (%) 23 of 60 (38) 
Senior physicians, n of N1 (%) 35 of 60 (58) 
Resident physicians, n of N1 (%) 25 of 60 (42) 
Anesthesia experience in years, M (IQR) 8, IQR 4-11  
Number of annually interpreted ROTEM readings per physician, M (IQR) 40, IQR 10-53 
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Part I: Qualitative analysis of interview answers 
The analysis of the word count showed the following twelve most frequently occurring words or word 
groups in the participants’ field note responses: visual/visualization/visually (24 of 36 participants, 
67%), easy/easier/easily (18 of 36 participants, 50%), ROTEM (18 of 36 participants, 50%), 
interpretation/interpret/interpreting (13 of 36 participants, 36%), presentation (12 of 36 participants, 
33%), good (11 of 36 participants, 31%), clear (11 of 36 participants, 31%), 
simple/simplification/simplicity (10 of 36 participants, 28%), understand/understood/understandable 
(10 of 36 participants, 28%), quick/quicker/quickly (6 of 36 participants, 17%), cut-off/cut-off values 
(6 of 36 participants, 17%), and hyperfibrinolysis (6 of 36 participants, 17%). Figure 2 provides the tag 
cloud created from the word count of the field note responses. 
Through inductive, free coding, we identified eight major topics with associated subthemes. Figure 3 
displays the generated coding template, which was used as a coding system. The two study authors TRR 
and DWT rated all thirty-six field note responses independently. A total of 131 codes were assessed. 
Inter-rater reliability was 71%, with a Cohen’s Kappa of 0.665 agreement. After the first run, TRR and 
DWT discussed all differences and agreed on a coding for the case of disagreement. The second run 
showed an inter-rater agreement of 100% between the coding of TRR and DWT. Table 2 outlines all 
major topics with associated subthemes and participant counts, percentages and examples. 
Figure 2. A tag cloud as a quantitative graphic illustration of the most common words in the interview 
field notes. This word cloud was created using Wordle.net. Common English words such as “the, and, 
to” are not displayed. Frequently occurring terms have larger font sizes.  
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Figure 3. The coding template displaying the major topics and associated subthemes. We generated this 
through deductive coding via word count and inductive, free coding of recurring topics in the interview 
field notes. A total of 36 participants were interviewed. 
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Table 2. The major topics and associated subthemes with participant count, percentages and examples. 
N = 36 
Major topics Subthemes Examples 
Positive design features  
(29 participants, 81%) 
Intuitive design  Participant #15: Intuitive kind of 
presentation. 
 Clear visualization  Participant #7: Clear presentation, no 
unnecessary information to distract.  
 Innovative idea  Participant #1: Obviously, something like 
this was missing. 
Facilitates decision 
making  
(17 participants, 47%) 
 Participant #19: Creates clarity in 
emergency situations. 
 Gives safety in decision 
making 
Participant #30: Perceived diagnostic 
confidence is higher. 
Saves cognitive resources 
(15 participants, 42%) 
Less brainwork needed  Participant #9: Don`t have to think as 
much as with conventional ROTEM.  
 Easy understanding of 
complex topic  
Participant #16: Couldn’t imagine, that it 
could be presented in such a simple 
way! 
Easy to learn  
(14 participants, 39%) 
 Participant #05: Even without extensive 
previous education.  
Participant #33: Easy. Self-explaining. 
Participant #13: Fast learning.  
Accelerates treatment  
(13 participants, 36%) 
 
Quick recognition of 
situation 
Participant #19: You can see immediately 
where the problem is. 
Participant #24: Quickly realize what 
the problem is. 
 Time saving  Participant #26: Faster with the Visual 
Clot.  
Participant #30: You get the answer 
much faster.  
User groups  
(9 participants, 25%) 
 Participant #25: Can be used safely by all 
educational levels. 
   
Quantification not made  
(17 participants, 47%) 
 Participant #14: No quantitative data 
or information. 
Negative design features  
(17 participants, 47%) 
Hyperfibrinolysis 
confusing  
Participant #22: Missing fibrin is not 
detected and understood easily.  
 Heparin unclear Participant #23: Heparin effect is a little 




Positive design features. Of the total of thirty-six participants, twenty-nine (81%) made comments that 
fit the major topic positive design features. After additional inductive, free coding, this topic is further 
divided into the three subthemes “intuitive design”, “clear visualization” and “innovative idea”. Some 
participants perceived the visualization as intuitive, while others pointed out its clear visualization of 
standard ROTEM results. Participant #7 stated that there are no unnecessary information to distract. 
Others indicated Visual Clot as innovative as they perceived this idea to be missing.  
Facilitates decision making. Seventeen of 36 participants (47%) noticed during the interview process 
how Visual Clot technology facilitated their decision making fulfilling given task. After free inductive 
coding, this major topic is broken down into the subtheme “safety in decision making” as some of these 
participants mentioned this. Participant #2 stated how using Visual Clot made him less afraid of getting 
involved with the ROTEM analysis. Also, participant #19 pointed out that the simplicity of Visual Clot 
technology created clarity in emergency situations.  
Saves cognitive resources. Fifteen participants of 36 (42%) indicated that using Visual Clot, the user 
saves cognitive resources compared to standard ROTEM readings. The two subthemes “less brainwork 
needed” and “easy understanding of complex topic” are derived from this major topic. Some participants 
mentioned that they did not have to think as much using Visual Clot. Another participant reasoned that 
using Visual Clot, he did not need to memorize the cut-off values.  
Easy to learn. Fourteen of 36 participants (39%) remarked that Visual Clot technology is easy to learn. 
Participant #25 felt that after a short instruction, one is already able to use Visual Clot correctly.  
Accelerating treatment. Thirteen of 36 participants (36%) found Visual Clot to accelerate treatment. 
This major topic is subdivided into the aspects “quick recognition of situation” and “time saving”. Some 
participants mentioned that using Visual clot most of the information is visible at a single look. Further, 
it helps them to interpret the coagulation status faster.  
User groups. Nine of 36 participants (25%) made comments that fit the major topic user groups. All of 
them shared the opinion that Visual Clot would especially help an inexperienced user in the 
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interpretation of ROTEM readings. Participant #25 noted that the visualization technology can be safely 
used by all educational levels.  
Quantification not made. Of all thirty-six participants, seventeen (47%) had concerns about the 
missing quantitative data using Visual Clot. Participant #16 suggested to show the visualization 
technology and the conventional ROTEM results next to each other to overcome this issue. Some 
mentioned how Visual Clot does not show the extent of the coagulation disorder. Only one participant 
(Participant #2) was concerned about whether this technology was reliable.  
Negative design features. Seventeen of 36 participants (47%) made comments that fit the major topic 
“negative design features”. Reported problems in differentiating between hyperfibrinolysis and low 
fibrinogen state was mentioned by several participants. Moreover, the heparin effect was difficult to 
interpret. Participant #1 found the Heparin visualization confusing.  
Part II: Quantitative analysis of statements rated in an online survey 
We chose six statements for the online survey and illustrate the ratings from the online survey in Figure 
4. The sample medians of statements two to six all differed statistically significantly from neutral. The 
first statement showed that half of the participants considered the use of ROTEM readings in the 
management of coagulopathies difficult, whereas the other half did not.  
Below we list the six statements with the evaluation of the online survey rating results:  
1. “I find the interpretation of the conventional presentation of the ROTEM and the management 
of coagulopathies difficult.” This statement does not differ statistically significantly from 
neutral (P =.54).  
2. “I find Visual Clot intuitive and I could learn the interpretation easily.” Thirty-nine of the 42 
participants (93%) agreed or strongly agreed to this statement (P <.001).  
3. “Visual Clot allows me to quickly grasp complex clotting situations.” Thirty-six of the 42 
participants (86%) agreed or strongly agreed to this statement (P <.001). 
4. “I think Visual Clot is helpful in the decision making process for a targeted therapy.” Thirty-
four of the 42 participants (81%) agreed or strongly agreed to this statement (P <.001). 
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5. “I required more cognitive resources for the interpretation of Visual Clot than for the 
interpretation of the conventional ROTEM.” One of the 42 participants (2%) agreed to this 
statement (P <.001). 
6.  “I would find it helpful to have the visualization of Visual Clot and the conventional ROTEM 
on the screen next to each other.” Thirty-eight of the 42 participants (90%) agreed or strongly 
agreed to this statement (P <.001). 
Figure 4. This figure presents the online survey results as donut part of whole charts with the number 
of participants who chose a particular category. We present the results as medians and interquartile 




This mixed methods study analyzed the opinions of physicians regarding Visual Clot, a new situation-
awareness oriented visualization technology for viscoelastic coagulation management. The main 
findings were that the participants perceived Visual Clot as intuitive, easy to learn and helpful in the 
decision making process for ROTEM-guided coagulation management. Further, they found that Visual 
Clot gave them a good overview of the clotting situation. The main criticism concerned its missing 
quantification. The participants would prefer this visualization on a screen next to the conventional 
ROTEM readings. In an environment, where health care providers are confronted with increasingly 
polymorbid patients and complicated diagnostic tools [20, 21], more efficient assistive technologies 
leading to safer transmission of critical information will be of lasting importance for human performance 
and patient safety.  
Our study showed a high level of physician acceptance and satisfaction with the new tool. Eighty-one 
percent of the participants regarded the animated blood clot as useful in the decision making process for 
coagulation management. Only one participant (2%) agreed to the statement "I required more cognitive 
resources for the interpretation of Visual Clot than for the interpretation of conventional ROTEM." 
These participant responses corresponded to the reactions to the similarly well-accepted Visual Patient 
technology [22]. There, only 11% of the questioned subjects considered that technology not helpful in 
patient monitoring after their first contact with it [23]. Visual Patient is a situation awareness-oriented 
visualization for patient vital signs with comparable effect size in information transfer improvement as 
Visual Clot [24-28]. Ninety-three percent of the participants considered Visual Clot intuitive to interpret 
and easy to learn. In the Visual Patient study [23], 82% percent of the respondents attributed the same 
characteristics to Visual Patient. The higher complexity of Visual Patient with far more visualizations 
may have caused the 10% difference in this aspect between the two technologies. Intuition enables 
humans to apply a new tool utilizing mainly unconscious processing and previously learned experiential 
knowledge [29]. Cognitive ease when learning a new technology is crucial for user acceptance [30]. 
Indeed, previous medical visualization technologies failed because they were too difficult to understand 
[31, 32]. We drafted Visual Clot and its visualizations based on principles of logic, human-computer 
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interaction, and results of prior work in medical interface and user-centered design [33, 34]. According 
to Wittgenstein’s theory [35], a coherent image or model has a meaningful commonality with the reality 
it is intended to reflect. To achieve this, we designed Visual Clot as a model of a blood clot. This 
philosophy is in line with results from Wachter et al., which show that an anatomically correct interface 
is particularly intuitive [36]. The referenced NASA publication outlines the various hierarchical levels 
of information representation [37]. It highlights the “order of wholeness” achieved by integrating the 
required information into a single display as the highest level of such presentation. In order to increase 
the cognitive receptiveness of information, we intentionally animated Visual Clot in a playful way [29, 
38]. This enhances user accessibility to the otherwise dry data-driven conventional result printouts. 
Before taking part in this study, none of the participants had ever seen Visual Clot technology. However, 
the number of correct decisions, time to decision, diagnostic confidence, and workload improved 
significantly with the new tool(15) compared to conventional ROTEM result presentation. This study 
reveals high agreement between the user perceptions and the function of the technology described in the 
previous Visual Clot study. This correspondence between expected and provided function is another 
essential feature for the success of new technologies. If this agreement does not occur, it can lead to 
false expectations, frustration and ultimately reduced user acceptance. The largest part of the answers 
given concerning its design features were positive (29 participants, 81%). Nevertheless, we identified 
some design features which led to confusion. For example, one visualization aimed to show that a test 
for heparin was carried out but turned out negative. This visualization intended to show an excluded 
heparin effect, but it confused some participants. For this reason, we modified the current version of 
Visual Clot. Now, it only displays heparin binary as present or not present. This is more in line with its 
situation awareness-oriented intention to show only essential information about coagulation disorders. 
Moreover, based on the participants' feedback we further refined the visualization of hyperfibrinolysis 
and fibrin deficiency. We follow both quantitative (i.e. participants’ performance with a particular 
visualization) and qualitative study results in such design modifications. Qualitative feedback is often 
valuable to understand why a particular visualization is not working. This provides clues on how we can 
adapt it. 
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Eighty-six percent of the participants agreed to the statement that Visual Clot allowed them to grasp 
complex coagulation situations more quickly. Ninety percent of the participants would find it helpful to 
have Visual Clot and the conventional ROTEM on the screen next to each other. We regard such an 
integrated display mode as optimal as Visual Clot technology converts the continuous numerical values 
of standard test outputs into categorical visualizations. For example, there can be too little, a healthy 
amount of, or too many platelets. This simplification has the advantage that information is understood 
quickly and easily, bearing in mind that this reduces the resolution of given data. Indeed, forty-seven 
percent of the interview participants made comments regarding the missing quantification of the 
disorders using Visual Clot. Hence, an ideal implementation must combine the benefits of Visual Clot, 
which is fast and easy situation recognition, with the high precision advantage of the conventional 
method. A hospital may configure the visualizations limits of Visual Clot according to the values of the 
local coagulation algorithm. This could help enforce the local standard procedure.  
The main goal of Visual Clot technology is still to simplify complex viscoelastic test results in real-time 
to facilitate the care providers` overview of the clotting situation. This study showed how potential future 
users perceived this technology after using it for the first time. Opinions such as its good and clear 
visualizations or how they were able to grasp a good overview over the clotting situation in a time-
efficient manner fully supports our main intention. Acutely bleeding patients benefit from faster and 
more accurate diagnosis and treatment. This study made us aware about the desire of our fellow 
physicians for such technology, from which we can draw fundamental motivation to further develop its 
concept. 
Limitations 
This study has several limitations. The opinions obtained cannot be extrapolated to a larger population 
because qualitative research does not investigate statistical significance. Its only goal is to collect and 
present the broadest possible range of opinions and views. Secondly, we asked the participants after 
their first contact with the new technology in a controlled instruction setting. Its use in the everyday 
clinical routine could alter the care providers` opinion. However, we consider it unlikely that Visual 
Clot would not be perceived as positively in clinical routine as it was in this study setting, as we observed 
widespread approval by anesthesiologists and intensive care physicians, the potential future users. 
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Nevertheless, further research is needed to identify the strengths and weaknesses of Visual Clot 
technology in a clinical setting. Another limitation concerns the selection of participants. We did not 
include them randomly, but according to their availability in the daily clinical routine. However, the 
high participation rate in the quantitative analysis reduces potential selection bias. Finally, we conducted 
this study in university hospitals with high standards of care in central Europe. Users' opinions may be 
different in other parts of the world. More research is needed in this respect as well. 
Conclusions 
A group of anesthesiologists and intensive care physicians regarded Visual Clot to be intuitive, easy to 
learn, and useful for the decision making process in acute clotting disorders. The limitations of the 
technology resulting from the translation of continuous measurement values into categorical ones was 
the most frequently mentioned potential disadvantage of the visualization technology. A split-screen 
implementation may be used to combine the advantages of both technologies. In this study, Visual Clot 
appeared to be a well-accepted decision support tool for ROTEM-based coagulation management. 
Further research is needed to investigate its potential in clinical practice and medical education. 
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